| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US97381707P | 2007-09-20 | 2007-09-20 | |
| US2323408P | 2008-01-24 | 2008-01-24 | |
| US2322708P | 2008-01-24 | 2008-01-24 | |
| US2323008P | 2008-01-24 | 2008-01-24 | |
| US4874708P | 2008-04-29 | 2008-04-29 | |
| US4876908P | 2008-04-29 | 2008-04-29 | |
| US4875608P | 2008-04-29 | 2008-04-29 | |
| PCT/US2008/076707WO2009039195A1 (en) | 2007-09-20 | 2008-09-17 | Resveratrol-containing compositions for modulating gene product concentration or activity |
| Publication Number | Publication Date |
|---|---|
| EP2197434A1 EP2197434A1 (en) | 2010-06-23 |
| EP2197434A4true EP2197434A4 (en) | 2011-08-10 |
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP08831905AWithdrawnEP2197434A4 (en) | 2007-09-20 | 2008-09-17 | COMPOSITIONS CONTAINING RESVERATROL FOR MODULATING THE CONCENTRATION OR ACTIVITY OF A GENE PRODUCT |
| Country | Link |
|---|---|
| EP (1) | EP2197434A4 (en) |
| JP (2) | JP2010540444A (en) |
| CA (1) | CA2699908C (en) |
| WO (1) | WO2009039195A1 (en) |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8263051B2 (en)* | 2007-08-09 | 2012-09-11 | Hallstar Innovations Corp. | Photostabilization of resveratrol with alkoxycrylene compounds |
| JP5979810B2 (en)* | 2009-10-09 | 2016-08-31 | 株式会社山田養蜂場本社 | Anti-aging agent |
| EP2525791A2 (en)* | 2010-01-21 | 2012-11-28 | INSERM - Institut National de la Santé et de la Recherche Médicale | Special composition for the use thereof as a drug |
| US20120058088A1 (en)* | 2010-06-28 | 2012-03-08 | Resveratrol Partners, Llc | Resveratrol-Containing Compositions And Methods Of Use |
| WO2013074948A1 (en) | 2011-11-16 | 2013-05-23 | Resveratrol Partners, Llc | Compositions containing resveratrol and nucleotides |
| JP5608629B2 (en)* | 2011-11-28 | 2014-10-15 | アピオン・ジャパン有限会社 | Sirtuin 1 (SIRT1) gene activator and telomerase reverse transcriptase (TERT) gene activator |
| AU2013315371A1 (en) | 2012-09-12 | 2015-04-09 | Berg Llc | Use of markers in the identification of cardiotoxic agents |
| CN102908338B (en)* | 2012-11-20 | 2014-05-14 | 晨光生物科技集团天津有限公司 | Preparation method of resveratrol microcapsule |
| US9138453B2 (en) | 2013-10-14 | 2015-09-22 | Biomarker Pharmaceuticals, Inc. | Nutrient combinations for affecting an aging process |
| JP5933633B2 (en)* | 2014-06-18 | 2016-06-15 | アピオン・ジャパン有限会社 | Sirtuin 1 (SIRT1) gene activator and telomerase reverse transcriptase (TERT) gene activator |
| WO2016102985A1 (en)* | 2014-12-23 | 2016-06-30 | Barokes Pty Ltd. | Container for a consumable good, coated with a resveratrol containing layer |
| US10702571B2 (en) | 2015-12-03 | 2020-07-07 | The University Of North Carolina At Pembroke | Materials for cathepsin B enhancement and methods of use |
| JP6272946B2 (en)* | 2016-05-20 | 2018-01-31 | 株式会社山田養蜂場本社 | Anti-aging agent |
| CN118325899A (en) | 2017-01-23 | 2024-07-12 | 瑞泽恩制药公司 | HSD17B13 variants and their applications |
| MX2019012169A (en) | 2017-04-11 | 2019-12-11 | Regeneron Pharma | Assays for screening activity of modulators of members of the hydroxysteroid (17-beta) dehydrogenase (hsd17b) family. |
| EP4234719A3 (en) | 2017-10-11 | 2023-10-18 | Regeneron Pharmaceuticals, Inc. | Inhibition of hsd17b13 in the treatment of liver disease in patients expressing the pnpla3 i148m variation |
| JP6411624B2 (en)* | 2017-12-26 | 2018-10-24 | 株式会社山田養蜂場本社 | Anti-aging agent |
| CA3091146A1 (en) | 2018-03-21 | 2019-09-26 | Regeneron Pharmaceuticals, Inc. | 17.beta.-hydroxysteroid dehydrogenase type 13 (hsd17b13) irna compositions and methods of use thereof |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050158376A1 (en)* | 2003-10-23 | 2005-07-21 | Sardi William F. | Dietary supplement and method of processing same |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2006298876A (en)* | 2005-04-25 | 2006-11-02 | Saisentan Igaku Kenkyusho:Kk | Composition containing sirtuin-activating agent and used for treating various eye diseases |
| CN102125538B (en)* | 2003-05-27 | 2014-05-07 | 帝斯曼知识产权资产管理有限公司 | Novel nutraceutical compositions and use thereof |
| US20050096256A1 (en)* | 2003-07-01 | 2005-05-05 | President And Fellows Of Harvard College | Compositions for manipulating the lifespan and stress response of cells and organisms |
| CN1956733B (en)* | 2004-04-07 | 2012-10-10 | 白藜芦醇合伙人有限责任公司 | Nutritional supplement and its processing method |
| US20070212395A1 (en)* | 2006-03-08 | 2007-09-13 | Allergan, Inc. | Ocular therapy using sirtuin-activating agents |
| US20070149466A1 (en)* | 2005-07-07 | 2007-06-28 | Michael Milburn | Methods and related compositions for treating or preventing obesity, insulin resistance disorders, and mitochondrial-associated disorders |
| WO2007019344A1 (en)* | 2005-08-04 | 2007-02-15 | Sirtris Pharmaceuticals, Inc. | Imidazo [2,1-b] thiayole derivatives as sirtuin modulating compounds |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050158376A1 (en)* | 2003-10-23 | 2005-07-21 | Sardi William F. | Dietary supplement and method of processing same |
| Publication number | Publication date |
|---|---|
| CA2699908C (en) | 2012-09-11 |
| JP2010540444A (en) | 2010-12-24 |
| EP2197434A1 (en) | 2010-06-23 |
| CA2699908A1 (en) | 2009-03-26 |
| JP2014058574A (en) | 2014-04-03 |
| WO2009039195A1 (en) | 2009-03-26 |
| Publication | Publication Date | Title |
|---|---|---|
| EP2197434A4 (en) | COMPOSITIONS CONTAINING RESVERATROL FOR MODULATING THE CONCENTRATION OR ACTIVITY OF A GENE PRODUCT | |
| EP2151438A4 (en) | PHARMACEUTICAL PRODUCT CONTAINING PPAR AGONIST | |
| EP2207539A4 (en) | DISINFECTANT COMPOSITIONS FOR SKIN OR FOR SURFACES CONTAINING PLANT-BASED SUBSTANCES | |
| EP2190439A4 (en) | OSELTAMIVIR SYNTHESIS CONTAINING PHOSPHONATE CONGENERS HAVING ANTI-INFLUENZA ACTIVITY | |
| EP2100610A4 (en) | PHARMACEUTICAL COMPOSITION CONTAINING LOW SUBSTITUTED HYDROXYPROPYLCELLULOSE | |
| EP1980320A4 (en) | PHOTOCATALYST MATERIAL AND PHOTOCATALYST COMPOSITION AND PHOTOCATALYST PRODUCT CONTAINING SAME | |
| EP2055308A4 (en) | PHARMACEUTICAL PRODUCT FOR PROMOTING FUNCTIONAL REGENERATION OF DAMAGED FABRIC | |
| EP2200573A4 (en) | RESVERATROL FERTILATE COMPOUNDS, COMPOSITIONS CONTAINING THE SAID COMPOUNDS AND METHODS OF USE THEREOF | |
| FR2904294B1 (en) | HEAD OF DISTRIBUTION OF FLUID PRODUCT. | |
| MA28078A1 (en) | PHARMACEUTICAL PRODUCTS CONTAINING BISPHOSPHONATES | |
| FR2913341B1 (en) | DEVICE FOR DISPOSABLE EJECTION OF A LIQUID OR PASTY PRODUCT | |
| EP2018872A4 (en) | PHARMACEUTICAL PRODUCT | |
| FR14C0020I1 (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING FENTANYL FOR NASAL APPLICATION | |
| EP2637674A4 (en) | COMPOUNDS CONTAINING BISMUTH FOR MODULATING THE PROPERTIES OF BIOLOGICALLY ACTIVE AGENTS | |
| EP2213296A4 (en) | MEDICINAL COMPOSITION CONTAINING EXTREMELY FUNCTIONALIZED CHIMERIC PROTEIN | |
| EP2164978A4 (en) | COMPOSITIONS AND METHODS FOR MODULATING ADAMTS13 ACTIVITY | |
| EP2354224A4 (en) | NOVEL PROTEIN HAVING FRUCTOSYL-VALYL-HISTIDINE OXIDASE ACTIVITY AND MODIFIED PRODUCT THEREOF AND USE OF THE PROTEIN OR MODIFIED PRODUCT | |
| EP2138489A4 (en) | NOVEL PYRIMIDINE COMPOUND HAVING A BENZYL (HETEROCYCLIQUEMETHYL) AMINE STRUCTURE AND PHARMACEUTICAL PRODUCT CONTAINING THE SAME | |
| FR2882349B1 (en) | HEAD OF DISTRIBUTION OF FLUID PRODUCT. | |
| EP2089354A4 (en) | NAPHTHALENYLOXYPROPENYL DERIVATIVES HAVING HISTONE DEACETYLASE INHIBITORY ACTIVITY AND A PHARMACEUTICAL COMPOSITION CONTAINING THE SAME | |
| EP2307056A4 (en) | STABLE AQUEOUS PHARMACEUTICAL COMPOSITIONS CONTAINING PARACETAMOL | |
| FR2878835B1 (en) | FLUID PRODUCT DISPENSING ASSEMBLY | |
| FR2887623B1 (en) | DEVICES AND METHODS FOR DETERMINING THE INDIVIDUALLY USED QUANTITY OF A SHARED PRODUCT | |
| EP2484349A4 (en) | INHIBITOR OF ACTIVITY HEPARANASE, AGENT ENHANCING WRINKLES CONTAINING THE SAME, AND PHARMACEUTICAL COMPOSITION | |
| EP2285215A4 (en) | NOVEL COMPOUNDS, PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME, AND METHODS OF USE THEREOF |
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase | Free format text:ORIGINAL CODE: 0009012 | |
| 17P | Request for examination filed | Effective date:20100329 | |
| AK | Designated contracting states | Kind code of ref document:A1 Designated state(s):AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR | |
| AX | Request for extension of the european patent | Extension state:AL BA MK RS | |
| DAX | Request for extension of the european patent (deleted) | ||
| A4 | Supplementary search report drawn up and despatched | Effective date:20110708 | |
| RIC1 | Information provided on ipc code assigned before grant | Ipc:A61K 31/7056 20060101ALI20110704BHEP Ipc:A61K 31/05 20060101AFI20110704BHEP | |
| 17Q | First examination report despatched | Effective date:20130715 | |
| STAA | Information on the status of an ep patent application or granted ep patent | Free format text:STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN | |
| 18D | Application deemed to be withdrawn | Effective date:20150401 |